All contributors
Onconephrology contributor
Richardson, Paul G
Primarily Myeloma cast nephropathy#28 of 46 recognizedHonor roll
35
Clinical papers
6,771
Citations (iCite)
8 / 8
First / senior author
2002–2024
Active years
Output over time
Clinical corpus papers per year — peak 4 in 2007, 2010, 2022.
- 2002: 1 paper
- 2005: 1 paper
- 2006: 1 paper
- 2007: 4 papers
- 2008: 1 paper
- 2009: 2 papers
- 2010: 4 papers
- 2011: 1 paper
- 2012: 2 papers
- 2013: 1 paper
- 2014: 2 papers
- 2016: 3 papers
- 2018: 1 paper
- 2019: 1 paper
- 2020: 2 papers
- 2021: 2 papers
- 2022: 4 papers
- 2023: 1 paper
- 2024: 1 paper
20022024
Subfield mix
Clinical papers by onconephrology subfield (a paper can count in more than one).
Myeloma cast nephropathy34
MGRS & paraprotein kidney disease7
Cellular therapy renal effects2
Frequent co-authors
Other recognized contributors who most often share corpus papers with Richardson (shared-paper count).
Agents they study
Catalog agents whose clinical kidney literature lists Richardson among the leading contributors (clinical-paper count on that agent).
Verify
Representative recent papers, and this author’s full PubMed bibliography.
A code-tallied bibliometric profile from PubMed + NIH iCite, restricted to human/clinical papers across a 15,541-article corpus (regenerated 2026-10-02). Recognition of published contribution — not a verdict on merit or influence, and not medical advice.